Aimmune Therapeutics, Inc. Separation Agreements
3 Contracts & Agreements
- Transition and Separation Agreement, dated November 5, 2017, by and between the Company and Stephen G. Dilly, M.B.B.S., Ph.D (Filed With SEC on November 6, 2017)
- TRANSITION AND SEPARATION AGREEMENT (Filed With SEC on February 3, 2017)
- TRANSITION AND SEPARATION AGREEMENT (Filed With SEC on November 4, 2015)